Investment Thesis
Newton Biocapital invests in promising solutions for chronic health conditions, leveraging scientific and medical expertise to support portfolio companies through proactive board involvement and program selection in preclinical and clinical stages.
Stage Focus
Preclinical to clinical-stage companies
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Chronic health conditions, preclinical and clinical programs, medical technologies, disease-focused solutions
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€60,275,000 - €77,775,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...